Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spatiotemporal Landscape of Kidney Tubular Responses to Glomerular Proteinuria.
Faivre A, Bugarski M, Rinaldi A, Sakhi IB, Verissimo T, Legouis D, Correia S, Kaminska M, Dalga D, Malpetti D, Cippa PE, de Seigneux S, Hall AM. Faivre A, et al. Among authors: hall am. J Am Soc Nephrol. 2024 Apr 24. doi: 10.1681/ASN.0000000000000357. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 38652545
Making narrative feedback meaningful.
Hall AM, Gray A, Ragsdale JW. Hall AM, et al. Clin Teach. 2024 Apr 23:e13766. doi: 10.1111/tct.13766. Online ahead of print. Clin Teach. 2024. PMID: 38651603
Behind the eightball.
Gray A, Hall AM, Hofmann H, Vick S. Gray A, et al. Among authors: hall am. J Hosp Med. 2024 May;19(5):413-416. doi: 10.1002/jhm.13346. Epub 2024 Apr 1. J Hosp Med. 2024. PMID: 38558530 No abstract available.
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity.
Agrez M, Chandler C, Thurecht KJ, Fletcher NL, Liu F, Subramaniam G, Howard CB, Blyth B, Parker S, Turner D, Rzepecka J, Knox G, Nika A, Hall AM, Gooding H, Gallagher L. Agrez M, et al. Among authors: hall am. Sci Rep. 2023 Nov 13;13(1):19741. doi: 10.1038/s41598-023-47229-y. Sci Rep. 2023. PMID: 37957274 Free PMC article.
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
Hall MS, Teer JK, Yu X, Branthoover H, Snedal S, Rodriguez-Valentin M, Nagle L, Scott E, Schachner B, Innamarato P, Hall AM, Blauvelt J, Rich CJ, Richards AD, Ceccarelli J, Langer TJ, Yoder SJ, Beatty MS, Cox CA, Messina JL, Abate-Daga D, Mule JJ, Mullinax JE, Sarnaik AA, Pilon-Thomas S. Hall MS, et al. Among authors: hall am. J Immunother Cancer. 2023 Oct;11(10):e007288. doi: 10.1136/jitc-2023-007288. J Immunother Cancer. 2023. PMID: 37802604 Free PMC article.
287 results